September 5, 2017 Issue of JAMA

September 5, 2017, Vol 318, No. 9, Pages 771-878

This Week in JAMA

Highlights

Abstract Full Text

free access has audio

JAMA. 2017;318(9):771-773. doi:10.1001/jama.2016.13289

Podcast: Outreach for colon cancer screening, mutation detection in advanced cancer, vision screening in children, and more

Original Investigation

Effect of Colonoscopy Outreach vs Fecal Immunochemical Test Outreach on Colorectal Cancer Screening Completion: A Randomized Clinical Trial

Amit G. Singal, MD, MS; Samir Gupta, MD, MSCS; Celette Sugg Skinner, PhD; et al.

Abstract Full Text

free access

JAMA. 2017;318(9):806-815. doi:10.1001/jama.2017.11389

This randomized clinical trial conducted in an urban safety-net health system compares the effectiveness of fecal immunochemical test outreach and colonoscopy outreach to increase completion of the screening process (screening initiation and follow-up) within 3 years.

Editorial
Using Outreach to Improve Colorectal Cancer Screening
Michael Pignone, MD, MPH; David P. Miller Jr, MD, MS

JAMA

Effect of Physician Notification Regarding Nonadherence to Colorectal Cancer Screening on Patient Participation in Fecal Immunochemical Test Cancer Screening: A Randomized Clinical Trial

Cédric Rat, MD, PhD; Corinne Pogu, MD; Delphine Le Donné, MD; et al.

Abstract Full Text

free access

JAMA. 2017;318(9):816-824. doi:10.1001/jama.2017.11387

This cluster randomized trial compares the effect on successful colorectal cancer (CRC) screening of 2 physician notification types (patient-specific vs regional nonresponse to a CRC screening invitation) vs no notification.

Editorial
Using Outreach to Improve Colorectal Cancer Screening
Michael Pignone, MD, MPH; David P. Miller Jr, MD, MS

JAMA

Preliminary Communication

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing

Diana Mandelker, MD, PhD; Liying Zhang, MD, PhD; Yelena Kemel, MS, ScM; et al.

Abstract Full Text

free access

JAMA. 2017;318(9):825-835. doi:10.1001/jama.2017.11137

This case series of patients with advanced cancer evaluates the proportion and potential clinical implications of inherited variants detected using DNA sequencing of tumor and normal tissue compared with genetic test results based on current guidelines.

Editorial
The Potential and Challenges of Expanded Germline Testing in Clinical Oncology
Eliezer M. Van Allen, MD

JAMA

Research Letter

Change in Medical Exemptions From Immunization in California After Elimination of Personal Belief Exemptions

Paul L. Delamater, PhD; Timothy F. Leslie, PhD; Y. Tony Yang, ScD, LLM, MPH

Abstract Full Text

free access

JAMA. 2017;318(9):863-864. doi:10.1001/jama.2017.9242

This study evaluates the statewide change in medical exemptions in the first year under California Senate bill 277 and if medical exemptions increased in regions with high personal belief exemption use prior to its enactment.

US Preventive Services Task Force

Recommendation Statement

Vision Screening in Children Aged 6 Months to 5 Years: US Preventive Services Task Force Recommendation Statement

US Preventive Services Task Force

Abstract Full Text

free access has audio

JAMA. 2017;318(9):836-844. doi:10.1001/jama.2017.11260

This Recommendation Statement from the US Preventive Services Task Force recommends vision screening at least once in all children aged 3 to 5 years to detect amblyopia or its risk factors (B recommendation) and concludes that evidence is insufficient to assess balance of benefits and harms of screening in children younger than 3 years (I statement).

Podcast: USPSTF Recommendation: Vision Screening in Children

Editorial
Vision Screening in Very Young Children鈥擬aking Sense of an Inexorable Diagnostic Process
William V. Good, MD

JAMA Pediatr

Evidence Report

Vision Screening in Children Aged 6 Months to 5 Years: Evidence Report and Systematic Review for the US Preventive Services Task Force

Daniel E. Jonas, MD, MPH; Halle R. Amick, MSPH; Ina F. Wallace, PhD; et al.

Abstract Full Text

free access

JAMA. 2017;318(9):845-858. doi:10.1001/jama.2017.9900

This Evidence Report and systematic review to support a 2017 US Preventive Services Task Force Recommendation Statement summarizes current evidence on benefits and harms of screening for and treatment of amblyopia, its risk factors, and refractive error in children aged 6 months to 5 years.

Editorial
Vision Screening in Very Young Children鈥擬aking Sense of an Inexorable Diagnostic Process
William V. Good, MD

JAMA Pediatr

Viewpoint

Management of Parkinson Disease in 2017: Personalized Approaches for Patient-Specific Needs

Michael S. Okun, MD

Abstract Full Text

has audio

JAMA. 2017;318(9):791-792. doi:10.1001/jama.2017.7914

This Viewpoint discusses the most recent advances in diagnosis of and treatment for Parkinson disease.

Podcast: Parkinson Disease

Considerations on the Off-label Use of Ketamine as a Treatment for Mood Disorders

Samuel T. Wilkinson, MD; Gerard Sanacora, MD, PhD

Abstract Full Text

JAMA. 2017;318(9):793-794. doi:10.1001/jama.2017.10697

This Viewpoint summarizes a number of important issues related to the clinical use of ketamine for the treatment of psychiatric disorders addressed in the consensus statement and provides suggestions for addressing remaining concerns.

The Nuremberg Code 70 Years Later

Jonathan D. Moreno, PhD; Ulf Schmidt, PhD; Steve Joffe, MD, MPH

Abstract Full Text

free access

JAMA. 2017;318(9):795-796. doi:10.1001/jama.2017.10265

This Viewpoint examines the impact that the Nuremberg Code has had on the history of biomedical research ethics and discusses its place at the intersection of contemporary medicine and politics.

A Piece of My Mind

Delivering Emotions

Elizabeth Corey, MD, MPH

Abstract Full Text

JAMA. 2017;318(9):797-798. doi:10.1001/jama.2017.7129

Editorial

Using Outreach to Improve Colorectal Cancer Screening

Michael Pignone, MD, MPH; David P. Miller Jr, MD, MS

Abstract Full Text

JAMA. 2017;318(9):799-800. doi:10.1001/jama.2017.10606

The Potential and Challenges of Expanded Germline Testing in Clinical Oncology

Eliezer M. Van Allen, MD

Abstract Full Text

JAMA. 2017;318(9):801-803. doi:10.1001/jama.2017.11022

Correcting the Medical Literature: 鈥淭o Err Is Human, to Correct Divine鈥�

Stacy Christiansen, MA; Annette Flanagin, RN, MA

Abstract Full Text

free access

JAMA. 2017;318(9):804-805. doi:10.1001/jama.2017.11833

Editorial
Public Access to Scientific Research Findings and Principles of Biomedical Research鈥擜 New Policy for the 糖心vlog
Kirsten Bibbins-Domingo, PhD, MD, MAS; Brian Shields, MBA; John Z. Ayanian, MD, MPP; Robert O. Bonow, MD, MS; Neil M. Bressler, MD; Dimitri Christakis, MD, MPH; Mary L. Disis, MD; S. Andrew Josephson, MD; Melina R. Kibbe, MD; Dost Öngür, MD, PhD; Jay F. Piccirillo, MD; Rita F. Redberg, MD, MPH; Frederick P. Rivara, MD, MPH; Kanade Shinkai, MD, PhD; Thomas J. Easley

JAMA

JAMA Insights

Genomics and Precision Health

Preimplantation Genetic Diagnosis for Mendelian Conditions

Siobhan M. Dolan, MD, MPH; Tamar H. Goldwaser, MD; Sangita K. Jindal, PhD

Abstract Full Text

has audio

JAMA. 2017;318(9):859-860. doi:10.1001/jama.2017.10892

This JAMA Insights article explains how preimplantation genetic diagnosis can help reduce the risk of inherited genetic conditions among newborns.

Podcast: How Couples With Genetic Disease Can Have Healthy Offspring

Medical News & Perspectives

Chess Study Revives Debate Over Cognition-Enhancing Drugs

Jeff Lyon

Abstract Full Text

JAMA. 2017;318(9):784-786. doi:10.1001/jama.2017.8114

This Medical News article explores the nonmedical and medical uses of cognition enhancing drugs.

News From the Food and Drug Administration

Combination Drug for HCV Infection

Rebecca Voelker, MSJ

Abstract Full Text

JAMA. 2017;318(9):790. doi:10.1001/jama.2017.10930

MRI for Neonates

Rebecca Voelker, MSJ

Abstract Full Text

JAMA. 2017;318(9):790. doi:10.1001/jama.2017.10934

New Formulation of Lupus Drug

Rebecca Voelker, MSJ

Abstract Full Text

JAMA. 2017;318(9):790. doi:10.1001/jama.2017.10937

The JAMA Forum

A Bipartisan 鈥淢oonshot鈥� in Health: Improving Care for High-Need Patients

Dave A. Chokshi, MD, MSc

Abstract Full Text

free access

JAMA. 2017;318(9):788-789. doi:10.1001/jama.2017.10801

Bench to Bedside

Organoids Reveal Clues to Gut-Brain Communication

Tracy Hampton, PhD

Abstract Full Text

JAMA. 2017;318(9):787-788. doi:10.1001/jama.2017.11545

Poetry and Medicine

What the Body Knows

Carol Snyder Halberstadt

Abstract Full Text

JAMA. 2017;318(9):870. doi:10.1001/jama.2017.2928

JAMA Revisited

鈥淔ound: A One Day Cure for Syphilis鈥�

Abstract Full Text

JAMA. 2017;318(9):871. doi:10.1001/jama.2017.10226

JAMA Patient Page

Vision Screening in Children

Jill Jin, MD, MPH

Abstract Full Text

free access

JAMA. 2017;318(9):878. doi:10.1001/jama.2017.11386

Comment & Response

High-Sensitivity Troponin Levels, Ischemia, and Mortality

Nathaniel R. Smilowitz, MD

Abstract Full Text

JAMA. 2017;318(9):864-865. doi:10.1001/jama.2017.9190

Spinal Manipulative Therapy for Low Back Pain

Romy Lauche, PhD; Tobias Sundberg, PhD; Holger Cramer, PhD

Abstract Full Text

JAMA. 2017;318(9):865-866. doi:10.1001/jama.2017.8837

High-Sensitivity Troponin Levels, Ischemia, and Mortality鈥擱eply

P. J. Devereaux, MD, PhD; Bruce M. Biccard, MBChB, MMedSci, PhD; Matthew T. V. Chan, MBBS, PhD

Abstract Full Text

JAMA. 2017;318(9):865. doi:10.1001/jama.2017.9198

Spinal Manipulative Therapy for Low Back Pain鈥擱eply

Neil M. Paige, MD, MSHS; Sally C. Morton, PhD; Paul G. Shekelle, MD, PhD

Abstract Full Text

JAMA. 2017;318(9):866. doi:10.1001/jama.2017.8841

Managing Conflicts of Interest in Practice Guidelines Panels

Yaolong Chen, PhD, MMed; Kehu Yang, MMed; Susan L. Norris, MD, MPH, MSc

Abstract Full Text

JAMA. 2017;318(9):866-867. doi:10.1001/jama.2017.9672

Managing Conflicts of Interest in Practice Guidelines Panels

Cristina Morciano, MSc; Carla Faralli, MA; Vittorio Basevi, MD

Abstract Full Text

JAMA. 2017;318(9):867-868. doi:10.1001/jama.2017.9676

Managing Conflicts of Interest in Practice Guidelines Panels鈥擱eply

Harold C. Sox, MD

Abstract Full Text

JAMA. 2017;318(9):868. doi:10.1001/jama.2017.9680

Correction

Caution Advised for Readers of Articles Related to Retracted Article

Abstract Full Text

free access

JAMA. 2017;318(9):868. doi:10.1001/jama.2017.10705

Editorial
Homocysteine and Fracture Prevention
Joyce B. J. van Meurs, PhD; André G. Uitterlinden, PhD

JAMA

November 2024 - July 1883

Decade

Year

Issue

September 5, 2017, Vol 318, No. 9, Pages 771-878

Recommendation Statement

Evidence Report

Genomics and Precision Health

Latest from the USPSTF